(PharmaNewsWire.Com, March 03, 2017 ) Growing incidence of viral diseases, rising aged population, technological advances in molecular diagnostics, increasing awareness about viral diseases and rising government initiatives in several regions are the key factors fueling the market growth. On the other hand, absence of skilled professionals and huge cost of molecular diagnostics are some of the key factors limiting the viral molecular diagnostics market growth. North America is the major market for the viral molecular diagnostics followed by the Western Europe owing to growing number of key players within this market. Superior infrastructure and top awareness levels about various viral diseases among the people in these regions are the key factors attributed for their highest share. Asia-Pacific is the fastest growing market for various viral molecular diagnostic tests, owing to growing incidence of viral infections in this market.
Some of the key players in the global viral molecular diagnostics market include Meridian Bioscience Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Corporation, BioMerieux SA, Auto Genomics Inc., Qiagen NV, Affymetrix Inc., Illumina Inc., Gen-Probe Inc., Roche Molecular Diagnostics, Siemens, Cepheid and Beckman Coulter.
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: